| 1 |
34954721 | Lipidomics in diabetes. | 2022 Apr 1 |
1 |
| 2 |
34962430 | Insulin regulates Nedd4-2 via a PKB-dependent mechanism in HEI-OC1 auditory cells-crosstalks with sphingolipid and cAMP signaling. | 2022 Jan |
2 |
| 3 |
35054078 | Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes. | 2022 Jan 13 |
1 |
| 4 |
35061523 | High intramuscular triglyceride turnover rates and the link to insulin sensitivity: influence of obesity, type 2 diabetes and physical activity. | 2022 Apr |
1 |
| 5 |
35066602 | A simple and rapid method for extraction and measurement of circulating sphingolipids using LC-MS/MS: a targeted lipidomic analysis. | 2022 Mar |
4 |
| 6 |
35111371 | Emerging Roles of Ceramide in Cardiovascular Diseases. | 2022 Feb |
1 |
| 7 |
35184720 | Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population. | 2022 Feb 20 |
2 |
| 8 |
35406045 | Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity. | 2022 Mar 30 |
5 |
| 9 |
35422650 | α-Lipoic Acid Reduces Ceramide Synthesis and Neuroinflammation in the Hypothalamus of Insulin-Resistant Rats, While in the Cerebral Cortex Diminishes the β-Amyloid Accumulation. | 2022 |
1 |
| 10 |
35470585 | Ceramide changes in abdominal subcutaneous and visceral adipose tissue among diabetic and nondiabetic patients. | 2022 Apr |
6 |
| 11 |
35508667 | Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis. | 2022 May 4 |
1 |
| 12 |
35584813 | The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease. | 2022 May 18 |
1 |
| 13 |
33158378 | Ceramides in Metabolism: Key Lipotoxic Players. | 2021 Feb 10 |
1 |
| 14 |
33268241 | Role of ceramides in the pathogenesis of diabetes mellitus and its complications. | 2021 Feb |
2 |
| 15 |
33492226 | [Is obesity-induced insulin resistance mediated by ceramide C18:0 synthesis de novo in skeletal muscles]. | 2021 Jan |
1 |
| 16 |
33504931 | A prospective study of maternal adiposity and glycemic traits across pregnancy and mid-childhood metabolomic profiles. | 2021 Apr |
1 |
| 17 |
33630410 | 1-Deoxyceramides - Key players in lipotoxicity and progression to type 2 diabetes? | 2021 May |
1 |
| 18 |
33738905 | Neutral sphingomyelinase-2 and cardiometabolic diseases. | 2021 Aug |
1 |
| 19 |
33815291 | Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes. | 2021 |
1 |
| 20 |
34004484 | Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies. | 2021 Jun |
1 |
| 21 |
34069652 | The Role of Fatty Acids in Ceramide Pathways and Their Influence on Hypothalamic Regulation of Energy Balance: A Systematic Review. | 2021 May 19 |
1 |
| 22 |
34197026 | Optical Nanosensors for Real-Time Feedback on Insulin Secretion by β-Cells. | 2021 Jul |
4 |
| 23 |
34257427 | Dietary carbohydrates and fats in nonalcoholic fatty liver disease. | 2021 Nov |
1 |
| 24 |
34273578 | Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders. | 2021 Nov |
1 |
| 25 |
34285405 | The aetiology and molecular landscape of insulin resistance. | 2021 Nov |
1 |
| 26 |
34288516 | Fuse your mitochondria, lose appetite: an anorexic, anti-obesity sphingolipid. | 2021 Aug 9 |
1 |
| 27 |
34417267 | Surplus Ceramides: An Added Twist in the Tale of TREM2 and Insulin Resistance. | 2021 Sep |
1 |
| 28 |
30803019 | Ceramides and diabetes mellitus: an update on the potential molecular relationships. | 2020 Jan |
2 |
| 29 |
31899812 | Ceramides: A Cause of Insulin Resistance in Nonalcoholic Fatty Liver Disease in Both Murine Models and Humans. | 2020 Apr |
1 |
| 30 |
32098447 | Influence of Exercise Training on Skeletal Muscle Insulin Resistance in Aging: Spotlight on Muscle Ceramides. | 2020 Feb 22 |
3 |
| 31 |
32144130 | Increased placental mitochondrial fusion in gestational diabetes mellitus: an adaptive mechanism to optimize feto-placental metabolic homeostasis? | 2020 Mar |
1 |
| 32 |
32392908 | Ceramide and Sphingosine 1-Phosphate in Liver Diseases. | 2020 May 31 |
1 |
| 33 |
32424203 | Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. | 2020 May 18 |
1 |
| 34 |
32430917 | Plasma Ceramides and Triglycerides Are Elevated during Pregnancy in Association with Markers of Insulin Resistance in Hutterite Women. | 2020 Jul |
4 |
| 35 |
32452372 | [Ceramides, crucial actors in the development of insulin resistance and type 2 diabetes]. | 2020 May |
3 |
| 36 |
32455838 | Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms-A Narrative Review. | 2020 May 21 |
3 |
| 37 |
32489964 | Genetic Architecture of Circulating Very-Long-Chain (C24:0 and C22:0) Ceramide Concentrations. | 2020 |
1 |
| 38 |
32636806 | Ceramides in Adipose Tissue. | 2020 |
1 |
| 39 |
32641420 | Systemic and heart autonomous effects of sphingosine Δ4 desaturase deficiency in lipotoxic cardiac pathophysiology. | 2020 Aug 14 |
1 |
| 40 |
32668665 | Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes. | 2020 Jul 13 |
1 |
| 41 |
32766878 | Distinct infrastructure of lipid networks in visceral and subcutaneous adipose tissues in overweight humans. | 2020 Oct 1 |
1 |
| 42 |
32821721 | Ceramides: Nutrient Signals that Drive Hepatosteatosis. | 2020 Jan |
2 |
| 43 |
32849276 | Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases. | 2020 |
2 |
| 44 |
33033923 | Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort. | 2020 Oct 8 |
1 |
| 45 |
33058843 | Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors. | 2020 Dec |
1 |
| 46 |
33219119 | Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans. | 2020 Nov |
1 |
| 47 |
33296380 | Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China. | 2020 Dec |
1 |
| 48 |
30071259 | Sphingolipid metabolism in non-alcoholic fatty liver diseases. | 2019 Apr |
1 |
| 49 |
30678043 | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells. | 2019 Jan 23 |
3 |
| 50 |
30871020 | Muscle-Saturated Bioactive Lipids Are Increased with Aging and Influenced by High-Intensity Interval Training. | 2019 Mar 12 |
2 |